Matching geography
Reports matching your search in:
 
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 
Region: All Regions > Africa
Category: All Categories > Life Sciences > Healthcare
(98 reports matching your criteria)
< prev 1    3  4  
Egypt Pharmaceuticals and Healthcare Report Q4 2014
10/29/2014 | published by: Business Monitor International
... forecast has been revised slightlyupwards. The government's increased emphasis on developing the pharmaceutical sector and theannounced expansion of the Medicare healthcare programme are positive developments this quarter. Thechallenges faced by pharmaceutical companies wishing to operate ...  |  read more...
USD 1,295
Healthcare Buildings Construction in South Africa to 2018: Market Databook
10/23/2014 | published by: Timetric
... construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the construction output and value-add ...  |  read more...
USD 500
Morocco Pharmaceuticals and Healthcare Report Q4 2014
10/22/2014 | published by: Business Monitor International
... the market over the medium-to-longterm, which will be driven by the growing middle class. However, the country's inefficient regulatoryenvironment, coupled with a weak healthcare infrastructure and poor health insurance cover, will continueto create difficult operating ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Ghana Q4 2014
10/15/2014 | published by: Business Monitor International
... market due to the increasing popularity of the National Health Insurance Scheme and the government'sgreater emphasis on the pharmaceutical sector and initiatives to combat the presence of counterfeitmedicines. Headline Expenditure Projections Pharmaceuticals: GHS859mn (USD416mn) in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - South Africa Q4 2014
10/8/2014 | published by: Business Monitor International
... investment is increasingly subduedand therefore catalysts for economic development are withdrawing. This will weigh on the pharmaceuticalmarket's development. Headline Expenditure Projections Pharmaceuticals: ZAR34.01bn (USD3.52bn) in 2013 to ZAR37.28bn (USD3.45bn) in 2014; +9.6% inlocal currency terms ...  |  read more...
USD 1,295
Zimbabwe Pharmaceuticals and Healthcare Report Q4 2014
9/24/2014 | published by: Business Monitor International
... in themedium-to-long term. The already dire situation, in which the health service is heavily reliant on donations,lacks skilled workers and essential medicines, and the fact that the vast majority of the healthcare budget isnot even ...  |  read more...
USD 1,295
Herbal/Traditional Products - Tunisia
9/12/2014 | published by: Euromonitor International
... shows a strong preference for standard products, increasingly focusing on affordable standard generics during the review period. Consequently, only a limited product range is available in herbal/traditional products. This includes topical analgesics/anaesthetic, medicated confectionery, cough/cold... ...  |  read more...
USD 900
Herbal/Traditional Products - Morocco
9/10/2014 | published by: Euromonitor International
... because of their more natural positioning. However, the penetration of herbal products, however, is still very low due to the narrow product portfolio which hampers overall sales growth. Euromonitor International's Herbal/Traditional Products in Morocco report ...  |  read more...
USD 900
Gabon Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... in poverty - especially in rural areas. Alleged corruption prevents a trickling down of oil revenues to the general population. After years ofplaying down the country's social problems, President Ali Bongo seems to have decided ...  |  read more...
USD 1,295
Botswana Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... developingpharmaceutical production within the country. Risks to our outlook include the continued presence ofcounterfeit pharmaceuticals and the forecast depreciation of the Botswana pula. Headline Expenditure Projections Pharmaceuticals: BWP1.62bn (USD193mn) in 2013 to BWP1.74bn (USD193mn) in ...  |  read more...
USD 1,295
Tanzania Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... especiallygiven spending levels in the previous fiscal year, and the fact that government expenditure tends to come inunder budget, in addition to the government's heavy reliance on aid. The country's rising population andincreasing urbanisation will ...  |  read more...
USD 1,295
Cote d'Ivoire Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... lack of policy enforcement and approvalsexpediency and a generally weak business setting. The healthcare market remains underdeveloped, whilethe burden of communicable diseases is considerable. Nevertheless, we have a more positive outlook foreconomic and pharmaceutical growth ...  |  read more...
USD 1,295
Herbal/Traditional Products - Algeria
9/9/2014 | published by: Euromonitor International
... and suffered from product shortages in 2012 as it struggled to meet demand. Digestive remedies thus saw 3% volume decline in 2012 before returning to half a percentage point growth in 2013. Similarly, PGT increased ...  |  read more...
USD 900
Cameroon Pharmaceuticals and Healthcare - Report Q4 2014
9/3/2014 | published by: Business Monitor International
... sectorimprovement in Cameroon over the medium term. These include mobile health technologies implementationin the fields of cardiology, HIV testing and personalised medical information across the country, as well ashospitals construction, foreign aid projects and different ...  |  read more...
USD 1,295
Nigeria Pharmaceuticals and Healthcare - Report Q4 2014
9/3/2014 | published by: Business Monitor International
... downside risk to increasinggovernment revenue, healthcare provision and medicines uptake over the long term. Currently, thegovernment remains committed to improving healthcare infrastructure and quality across the country. Wesee Nigeria as a standout market in West ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Namibia Q4 2014
8/27/2014 | published by: Business Monitor International
... approving a NAD400mn spendingallowance for the Ministry of Health and Social Services, to allow it to buy the drugs it needs. However, webelieve that healthcare access for many of the country's citizens is likely to ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Angola Q4 2014
8/27/2014 | published by: Business Monitor International
... attracting external revenues. Angola'shigh burden of communicable disease, such as measles and malaria, will mean that the demand forvaccines remain high. However, the country's pharmaceutical and healthcare market is greatly affected byits difficult operating environment, ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Mozambique Q4 2014
8/27/2014 | published by: Business Monitor International
... medicines and healthcare facilities. Vaccination programs and trials are being put into place, particularly for malaria and HIV immunisation,to help combat the county's high burden of disease. However, Mozambique's pharmaceutical market suffersfrom an abundance of ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Uganda Q4 2014
8/27/2014 | published by: Business Monitor International
... healthcare coverage which results in mostUgandans being unable to afford medicines, is placing a high level of strain on the country's ability toprovide adequate healthcare. Uganda also faces the threat of an Ebola outbreak spreading ...  |  read more...
USD 1,295
Algeria Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... as a strategic sector in the economy, will continue throughout Q414. A new memorandum of understanding between Pharmaceutical Research and Manufacturers of America(PhRMA) and Algeria's government indicates additional steps towards encouraging foreign directinvestment (FDI), and ...  |  read more...
USD 1,295
Zambia Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... to serve the district of Chienge. This,along with ongoing governmental training initiatives aimed at improving the skills of Zambian healthcareprofessionals, is likely to attract talent to the country. That said, speculation over President Sata's ill ...  |  read more...
USD 1,295
Kenya Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... healthcare spending between2013 and 2018. However, we note that there are downside risks to our forecast, including governmentinefficiencies and the out-of-pocket characteristics of the market, which will act as challenges forcompanies looking for a rapid ...  |  read more...
USD 1,295
Healthcare Buildings Construction in Egypt to 2018 : Market Databook
8/15/2014 | published by: Timetric
... including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the construction output and value-add methods. Summary ...  |  read more...
USD 500
Mauritius : Pharmaceuticals and Healthcare Report Q3 2014
8/6/2014 | published by: Business Monitor International
... growth will be slowdue to the limited capacity of local drugmakers. Headline Expenditure Projections Pharmaceuticals: MUR6.00bn (USD195mn) in 2013 to MUR6.56bn (USD220mn) in 2014; 9.35% growthin local currency terms. Healthcare: MUR17.44bn (USD567mn) in 2013 to ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Ghana
7/16/2014 | published by: Business Monitor International
... remain positive for the sectorwith the government's focus on domestic pharmaceutical sector, greater foreign pharmaceutical companyinterest in the country and capacity building initiatives for bringing global quality control standards toGhanaian pharmaceutical industry will spur domestic ...  |  read more...
USD 1,295
< prev 1    3  4